Patenting of Genetically Modified Organisms (GMOS): A Critical Analysis

Genetically modified organisms (GMOs) are subject to patent law, biotechnology, and ethical concerns, making it a complicated and contentious topic. The development of genetically modified organisms has become integral to improvements in environmental sustainability, agriculture, and medicine. GMO patents grant companies and inventors the exclusive right to use their innovations, encouraging creativity and financial investment in the field of biotechnology. However, the patenting process brings up ethical and legal issues, especially when it comes to who owns living things, possible control of the food supply, and the effects on farmers and agricultural biodiversity. Detractors assert that the commercialization of living organisms could inhibit technological advancement and grate customary farming methods, whereas proponents underscore the significance of patents in promoting scientific inquiry and innovation. This abstract discusses the trade off between innovation and societal impact when it comes to patenting GMOs, looking at significant legal decisions, regulatory frameworks, and righteous discussions related to this significant area of biotechnology.